QQQ   420.51 (-0.68%)
AAPL   165.35 (-1.01%)
MSFT   400.89 (-0.84%)
META   490.29 (-2.29%)
GOOGL   154.81 (-0.77%)
AMZN   176.92 (-1.28%)
TSLA   149.38 (-0.37%)
NVDA   828.45 (-2.16%)
AMD   151.96 (-2.01%)
NIO   3.87 (-3.25%)
BABA   68.81 (-0.10%)
T   16.42 (+0.55%)
F   12.14 (+0.66%)
MU   110.40 (-1.37%)
GE   152.07 (-0.57%)
CGC   8.07 (+3.07%)
DIS   112.17 (-0.23%)
AMC   3.06 (+4.79%)
PFE   25.47 (+0.32%)
PYPL   61.99 (-0.18%)
XOM   120.40 (+1.59%)
QQQ   420.51 (-0.68%)
AAPL   165.35 (-1.01%)
MSFT   400.89 (-0.84%)
META   490.29 (-2.29%)
GOOGL   154.81 (-0.77%)
AMZN   176.92 (-1.28%)
TSLA   149.38 (-0.37%)
NVDA   828.45 (-2.16%)
AMD   151.96 (-2.01%)
NIO   3.87 (-3.25%)
BABA   68.81 (-0.10%)
T   16.42 (+0.55%)
F   12.14 (+0.66%)
MU   110.40 (-1.37%)
GE   152.07 (-0.57%)
CGC   8.07 (+3.07%)
DIS   112.17 (-0.23%)
AMC   3.06 (+4.79%)
PFE   25.47 (+0.32%)
PYPL   61.99 (-0.18%)
XOM   120.40 (+1.59%)
QQQ   420.51 (-0.68%)
AAPL   165.35 (-1.01%)
MSFT   400.89 (-0.84%)
META   490.29 (-2.29%)
GOOGL   154.81 (-0.77%)
AMZN   176.92 (-1.28%)
TSLA   149.38 (-0.37%)
NVDA   828.45 (-2.16%)
AMD   151.96 (-2.01%)
NIO   3.87 (-3.25%)
BABA   68.81 (-0.10%)
T   16.42 (+0.55%)
F   12.14 (+0.66%)
MU   110.40 (-1.37%)
GE   152.07 (-0.57%)
CGC   8.07 (+3.07%)
DIS   112.17 (-0.23%)
AMC   3.06 (+4.79%)
PFE   25.47 (+0.32%)
PYPL   61.99 (-0.18%)
XOM   120.40 (+1.59%)
QQQ   420.51 (-0.68%)
AAPL   165.35 (-1.01%)
MSFT   400.89 (-0.84%)
META   490.29 (-2.29%)
GOOGL   154.81 (-0.77%)
AMZN   176.92 (-1.28%)
TSLA   149.38 (-0.37%)
NVDA   828.45 (-2.16%)
AMD   151.96 (-2.01%)
NIO   3.87 (-3.25%)
BABA   68.81 (-0.10%)
T   16.42 (+0.55%)
F   12.14 (+0.66%)
MU   110.40 (-1.37%)
GE   152.07 (-0.57%)
CGC   8.07 (+3.07%)
DIS   112.17 (-0.23%)
AMC   3.06 (+4.79%)
PFE   25.47 (+0.32%)
PYPL   61.99 (-0.18%)
XOM   120.40 (+1.59%)
Free Trial

Recursion Pharmaceuticals (RXRX) News Today

→ This company has increased its dividend every year for 54 years (From DTI) (Ad)
Free RXRX Stock Alerts
$7.32
-0.08 (-1.08%)
(As of 10:16 AM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media
SourceHeadline
insidertrades.com logoRecursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Director Blake Borgeson Sells 11,447 Shares
insidertrades.com - April 19 at 6:53 AM
insidertrades.com logoRecursion Pharmaceuticals, Inc. (NASDAQ:RXRX) CFO Michael Secora Sells 23,124 Shares
insidertrades.com - April 19 at 6:53 AM
marketbeat.com logoInsider Selling: Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Director Sells 11,447 Shares of Stock
marketbeat.com - April 18 at 6:51 PM
marketbeat.com logoSumitomo Mitsui Trust Holdings Inc. Buys 5,680,656 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)
marketbeat.com - April 18 at 5:57 AM
finance.yahoo.com logoRecursion Pharmaceuticals (RXRX) Dips More Than Broader Market: What You Should Know
finance.yahoo.com - April 17 at 9:13 PM
finanznachrichten.de logoRecursion Pharmaceuticals, Inc.: Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer
finanznachrichten.de - April 17 at 3:44 PM
fool.com logoWhere Will Recursion Pharmaceuticals Be in 5 Years?
fool.com - April 17 at 10:44 AM
globenewswire.com logoRecursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer
globenewswire.com - April 16 at 8:00 AM
marketbeat.com logoRecursion Pharmaceuticals (NASDAQ:RXRX) Stock Price Down 5.6%
marketbeat.com - April 15 at 5:31 PM
investorplace.com logoBiotech on a Budget: 7 Stocks Under $10 With Huge Potential
investorplace.com - April 15 at 12:54 PM
nasdaq.com logoValidea Detailed Fundamental Analysis - RXRX
nasdaq.com - April 10 at 3:25 PM
seekingalpha.com logoRevisiting Recursion: Big Bets, Big Data, And The Big Cash Burn Rate
seekingalpha.com - April 10 at 10:25 AM
marketbeat.com logoBaillie Gifford & Co. Sells 371,905 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)
marketbeat.com - April 10 at 8:24 AM
fool.com logoCan Recursion Pharmaceuticals Stock Double in 5 Years? Here's What It Would Take.
fool.com - April 10 at 5:50 AM
MarketBeat logoRecursion Pharmaceuticals (NASDAQ:RXRX) Given "Buy" Rating at Needham & Company LLC
americanbankingnews.com - April 10 at 4:16 AM
markets.businessinsider.com logoAnalyst Scoreboard: 5 Ratings For Recursion Pharmaceuticals
markets.businessinsider.com - April 9 at 1:46 PM
fool.com logoThe AI Advantage: 2 Healthcare Stocks at the Forefront of Innovation
fool.com - April 8 at 9:23 AM
insidertrades.com logoRecursion Pharmaceuticals, Inc. (NASDAQ:RXRX) CEO Sells $353,600.00 in Stock
insidertrades.com - April 6 at 7:39 AM
marketbeat.com logoInsider Selling: Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) CEO Sells 40,000 Shares of Stock
marketbeat.com - April 5 at 6:39 PM
fool.com logoIs This Under-the-Radar Artificial Intelligence (AI) Stock a Buy?
fool.com - April 4 at 8:45 AM
marketbeat.com logoVanguard Group Inc. Has $118.63 Million Stake in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)
marketbeat.com - April 4 at 4:11 AM
marketbeat.com logoRecursion Pharmaceuticals (NASDAQ:RXRX) Shares Gap Down Following Insider Selling
marketbeat.com - April 2 at 10:27 AM
insidertrades.com logoRecursion Pharmaceuticals, Inc. (NASDAQ:RXRX) CEO Sells $404,000.00 in Stock
insidertrades.com - April 2 at 4:14 AM
marketbeat.com logoRecursion Pharmaceuticals, Inc. (NASDAQ:RXRX) CEO Christopher Gibson Sells 40,000 Shares
marketbeat.com - April 1 at 9:24 PM
marketbeat.com logoRecursion Pharmaceuticals (NASDAQ:RXRX) Stock Price Down 5.5%
marketbeat.com - April 1 at 3:49 PM
marketbeat.com logoARK Investment Management LLC Has $203.65 Million Stock Holdings in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)
marketbeat.com - March 28 at 6:39 AM
globenewswire.com logoRecursion Publishes Annual Environmental, Social and Governance Report
globenewswire.com - March 26 at 8:00 AM
insidertrades.com logoRecursion Pharmaceuticals, Inc. (NASDAQ:RXRX) COO Sells $86,000.00 in Stock
insidertrades.com - March 26 at 4:44 AM
insidertrades.com logoRecursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Director Sells $216,382.66 in Stock
insidertrades.com - March 24 at 5:28 AM
marketbeat.com logoRecursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Director Blake Borgeson Sells 20,054 Shares
marketbeat.com - March 21 at 7:57 PM
marketbeat.com logoRecursion Pharmaceuticals (NASDAQ:RXRX) Trading Down 5.9%
marketbeat.com - March 21 at 5:42 PM
seekingalpha.com logoRecursion: Exercising Caution Prior To Q3 Data Release (Rating Downgrade)
seekingalpha.com - March 19 at 8:50 PM
marketbeat.com logoRecursion Pharmaceuticals (NASDAQ:RXRX) Shares Gap Down to $11.42
marketbeat.com - March 19 at 11:53 AM
finance.yahoo.com logoNew COVID-Like Outbreak 'Matter Of When, Not If,' WHO Director Warns As Scientists Race To Prepare Using Artificial Intelligence
finance.yahoo.com - March 18 at 4:05 PM
marketbeat.com logoRecursion Pharmaceuticals (NASDAQ:RXRX) Sees Strong Trading Volume
marketbeat.com - March 18 at 11:25 AM
insidertrades.com logoBlake Borgeson Sells 20,054 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Stock
insidertrades.com - March 17 at 7:58 AM
marketbeat.com logoCitigroup Inc. Purchases 293,174 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)
marketbeat.com - March 17 at 5:10 AM
insidertrades.com logoRecursion Pharmaceuticals, Inc. (NASDAQ:RXRX) CFO Sells $275,750.00 in Stock
insidertrades.com - March 15 at 11:25 AM
finance.yahoo.com logoRecursion Pharmaceuticals Inc CFO Michael Secora Sells 50,000 Shares
finance.yahoo.com - March 15 at 5:20 AM
marketbeat.com logoRecursion Pharmaceuticals, Inc. (NASDAQ:RXRX) CFO Michael Secora Sells 25,000 Shares
marketbeat.com - March 14 at 10:32 PM
theglobeandmail.com logo1 AI Growth Stock With 54% Upside Potential
theglobeandmail.com - March 14 at 2:19 PM
marketbeat.com logoRecursion Pharmaceuticals (NASDAQ:RXRX) Trading 5.5% Higher
marketbeat.com - March 13 at 1:51 PM
marketbeat.com logoRecursion Pharmaceuticals (NASDAQ:RXRX) Shares Down 6.1% After Insider Selling
marketbeat.com - March 11 at 2:36 PM
finanznachrichten.de logoRecursion Pharmaceuticals, Inc.: Recursion Announces Plans to Open New Office in London
finanznachrichten.de - March 11 at 7:58 AM
insidertrades.com logoInsider Selling: Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) CEO Sells 36,319 Shares of Stock
insidertrades.com - March 11 at 6:23 AM
globenewswire.com logoRecursion Announces Plans to Open New Office in London
globenewswire.com - March 11 at 4:00 AM
fool.com logoRecursion Pharmaceuticals Stock Has 33% Upside, According to 1 Wall Street Analyst
fool.com - March 7 at 10:28 AM
marketbeat.com logoRecursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Shares Purchased by UBS Group AG
marketbeat.com - March 5 at 5:18 AM
marketbeat.com logoKeyCorp Increases Recursion Pharmaceuticals (NASDAQ:RXRX) Price Target to $16.00
marketbeat.com - March 4 at 8:32 AM
finance.yahoo.com logoRecursion Hosts Second Annual Rare Disease Day Events for Utah’s Rare Disease Community
finance.yahoo.com - March 1 at 3:27 PM
Get Recursion Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for RXRX and its competitors with MarketBeat's FREE daily newsletter.

New crypto project uncovers 2,050% in 65 days (Ad)

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

RXRX Media Mentions By Week

RXRX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RXRX
News Sentiment
▼
0.24

0.52
▲
Average
Medical
News Sentiment

RXRX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RXRX Articles
This Week
▼
12

4
▲
RXRX Articles
Average Week

Get Recursion Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for RXRX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:RXRX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
Biden’s $374B Giveaway Into This Sector
DTI
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
How Biden has already won 2024
Porter & Company